It is a link to move in the page.
Move to main content area of this page.
Otsuka Pharmaceutical Factory,Inc. News Releases
(other than the above)
Otsuka Pharmaceutical Factory,Inc.
J.O. Pharma Co., Ltd. to expand its production facility in Izumo City (236KB)
Egypt Otsuka acquires an Egyptian intravenous infusion manufacturing and distribution company. (229KB)
Otsuka Pharmaceutical Factory Announces Personnel Changes (194KB)
Otsuka Pharmaceutical Factory launches “RACOL-NF Semi Solid for Enteral Use” on June 2, 2014 (268KB)
Otsuka Pharmaceutical Factory announces HINE E-GEL concentrated liquid nutrition product launched on
February 24,2014 (225KB)
Otsuka Pharmaceutical Factory launches a newly approved plasma substitute Voluven®6% on October 25, 2013 (153KB)
Otsuka Pharmaceutical Factory and Fresenius Kabi Japan enter into an exclusive distribution agreement of HES products, including the newly approved Voluven 6% (127KB)
Otsuka Pharmaceutical Factory and Mitsui enter into IV solutions business in India (290KB)
Otsuka Techno to Construct New Factory at Industrial Park in Naruto, Tokushima (267KB)
J.O. Pharma Co., Ltd. to construct a new manufacturing facility for
prefilled syringes (a syringe with injectable drug solution filled in advance): Signing of an agreement with Shimane Prefecture and Izumo City
for the facility construction (264KB)
Otsuka Pharmaceutical Factory and Living Cell Technologies Limited Agree to Establish Joint Venture to Develop and Commercialize Pancreatic Islets as a Treatment for Diabetes (217KB)
OTSUKA PHARMACEUTICAL FACTORY INVESTS IN LIVING CELL TECHNOLOGIES LIMITED,
A BIOTECHNOLOGY COMPANY ADVANCING DEVELOPMENT OF ENCAPSULATED PORCINE PANCREATIC ISLET REPLACEMENT TREATMENT (196KB)
There is no news at this time.
"HINE Jelly AQUA" Concentrated liquid nutrition product to be launched on November 4, 2009 (145KB)
ELNEOPA No. 1 Injection & ELNEOPA No. 2 Injection - the world's first TPN* solution formulated with five types of trace elements- to be launched September 28, 2009 in Japan (113KB)